The results showed that compared to the control group, tumor growth in the sh‐UBD group was significantly slowed, and in the sh‐UBD + anti‐PD‐L1 antibody treatment group, tumor growth was further inhibited, resulting in prolonged survival (Figure 6B). Here, CD274 is linked to neoplasm.